Novartis’ CAR-T gene therapy, the very first approved by FDA, to cost $475,000
Published: Aug 31, two thousand seventeen Two:14 p.m. ET
Concerns about how the therapy would be priced preceded its Wednesday approval
EmmaCourt
Novartis AG’s CAR-T cell therapy was approved by the Food and Drug Administration on Wednesday, making it the very first gene therapy to be available in the U.S. Contine reading